Sedana Medical AB (publ), interim report Q2, 2020
All-time-high sales and positive study resultFinancial Summary April-June · Net sales during the quarter amounted to KSEK 40 509 (17 359) corresponding to an increase of 133% compared with the same period in 2019. · Earnings before interest, taxes, depreciation and amortization (EBITDA) amounted to KSEK -777 (‑2 330). This corresponds to an EBITDA margin of -1,9% (-13,4%). · Earnings before interest and taxes (EBIT) amounted to KSEK -1 917 (-3 377) which corresponds to an EBIT margin of -4,7% (-19,5%). · Net income for the period was KSEK ‑3 595 (‑1 723) and earnings per share